10 Healthcare Stocks with Highest Dividends
In December, CNBC reported that health-care job growth is propping up the labor market at a time when many other industries are struggling.
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 11,985 | $2,929,584 | -15% | 1.47% |
| 2. | Zevenbergen Capital Investments Nancy Zevenbergen | 11,164 | $2,728,928 | +2% | 0.08% |
| 3. | Bourgeon Capital John Zaro | 10,154 | $2,482,044 | +1% | 0.43% |
| 4. | Sivik Global Healthcare Krishen Sud | 20,000 | $4,889 | 3.71% | |
| 5. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $206.15 | 1,250 | $257,687.50 | 1,849 | 2025-11-26 | Filing | |
| $145.53 | 100 | $14,553.00 | 250 | 2024-04-30 | Filing | |
| $147.22 | 1,000 | $147,220.00 | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | $63,843.00 | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | $706,399.00 | 5,000 | 2019-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $247.87 | 4,075 | $1,010,070.25 | 23,682 | 2026-02-27 | Filing | |
| $245.66 | 1,322 | $324,762.52 | 25,447 | 2026-02-20 | Filing | |
| $242.70 | 20,521 | $4,980,446.70 | 25,698 | 2026-02-17 | Filing | |
| $243.71 | 22,191 | $5,408,168.61 | 25,020 | 2026-02-13 | Filing | |
| $243.76 | 19,368 | $4,721,143.68 | 25,020 | 2026-02-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,998,885 | $1,710,807,535 | 42.46% | |
| 2. | 1,555,687 | $340,595,507 | 0.69% | |
| 3. | 892,187 | $217,734,289 | 1.18% | |
| 4. | 736,491 | $180,027,860 | 4.35% | |
| 5. | 672,703 | $164,435,481 | 2.37% |
News See All
Johnson & Johnson (NYSE:JNJ) Q1 2026 Earnings Call Transcript
Operator: Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded.
Jim Cramer's Game Plan for 12 Stocks and His Take on the Market Post Iran-U.S. Ceasefire Talks
In this article, we will look at the stocks on Jim Cramer’s game plan as he shared his take on the market post-Iran-U.S. ceasefire talks.
Johnson & Johnson (JNJ) is Gaining from Its Strong Innovative Medicine Growth
Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Strategy” first-quarter 2026 investor letter.
15 Best Low Volatility Blue Chip Stocks to Buy Now
The S&P 500 has declined by over 3.5% in 2026 so far. According to an April 1 report by CNBC, investors were being urged to brace for more volatility.
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
15 Best Stocks to Buy According to Billionaire Ray Dalio
Billionaire Ray Dalio recently took to social networking platform X to outline his thoughts on the current geopolitical situation and the impact it will have on global markets.
13 Best Diversified Dividend Stocks to Buy Right Now
Diversified stocks refer to companies that operate across multiple sectors, industries, or regions.
Johnson & Johnson (JNJ) Benefits from Growth Pipeline and Strength Across Key Therapeutic Areas
Ariel Investments, an investment management company, released its "Ariel Focus Fund" fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Iran Conflict Rattles Stocks — Jim Cramer’s Game Plan and 9 Stock Calls
In this article, we will look at everything Jim Cramer said regarding his latest game plan as the oil-shock-driven sell-off continues.
Hedge Fund Resource Center